The pharma major beat analysts’ expectations in the fourth quarter of 2024, despite looming competition for its top heart ...

German retail sales rose in 2024, but growth should be more modest this year due to the high level of uncertainty, according ...

Roche has reported a 7% increase in full-year 2024 sales at constant exchange rates (CER), reaching CHF 60.5bn ($66.9bn). The ...

General Dynamics faces challenges in the aerospace and submarine segments, impacting performance, but growth expected, ...

CEO Vas Narasimhan highlighted Novartis' strong performance in Q4 2024, with sales increasing 16% and core operating income rising 29% in constant currency. For the full year, the company achieved a ...

Two years after AbbVie’s loss of market exclusivity for Humira, those “How it Started and How it’s Going” memes are looking ...

Domestic formulation sales increased by 13.8 per cent to Rs 4,300.4 crore Y-o-Y, representing 32 per cent of the company's ...

Q4 2024 Management View CEO Rob Michael highlighted AbbVie's strong Q4 2024 performance, which exceeded initial guidance with ...

High-net-worth Individuals deploying money in Delhi-NCR - this region is home to over 10 recently-listed start-ups - has kept ...

AbbVie's acquisition of Allergan significantly increased the firm's debt level. We expect the firm's net debt position to peak at close to $70 billion in 2020 but given the strong cash flows of AbbVie ...

The industry hopes for more headroom for higher allocations for rural development schemes to pump up sales in smaller towns ...

Sartorius AG (SARTF) reports robust order growth and efficiency savings, despite facing headwinds in the Lab Products & Services division.